Index of reports
> Cases with Asthenia (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Atrovent (Ipratropium) where reactions include asthenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Atrovent side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-22
Patient: female, weighing 56.8 kg (125.0 pounds)
Reactions: Productive Cough, Skin Exfoliation, Tooth Deposit, Chapped Lips, Lower Respiratory Tract Infection, Oral Mucosal Exfoliation, Walking AID User, Poor Quality Sleep, Balance Disorder, Postoperative Wound Complication, Oral Candidiasis, Leukoplakia Oral, Cardiac Failure Congestive, Dyspnoea, Stomatitis, Pneumonia, Dysphagia, Oropharyngeal Plaque, Mass, Dental Caries, Drug Withdrawal Syndrome, Ill-Defined Disorder, Convulsion, Gingival Pain, Dysphonia, Oral Pain, Respiratory Tract Infection, Asthenia, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Atrovent
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-01
Flovent
Dosage: 2puff twice per day
Indication: Product Used FOR Unknown Indication
End date: 2010-11-01
Fluticasone Propionate / Salmeterol
Dosage: 1puff twice per day
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2010-11-01
Other drugs received by patient: Arimidex; Senokot; Vitamin D; Zinc Sulfate; Diclofenac Sodium; Albuterol Sulate; Bisacodyl; Glucosamine; Oxycodone HCL; Lyrica; Vitamin B Complex CAP; Alendronate Sodium; Calcium; Calcium Carbonate; Vitamin B1 TAB; Vitamin B-12; Lovaza; Listerine; Aspirin; Vitamin B6; Herceptin; Mouth Rinse; Pantoprazole Sodium; Diazepam; Gravol TAB; Folic Acid; Magnesium; Tylenol W / Codeine NO. 3; Symbicort; Oxycodone HCL; Metoclopramide
Possible Atrovent side effects in female
Reported by a consumer/non-health professional from Canada on 2012-06-04
Patient: female, weighing 56.8 kg (125.0 pounds)
Reactions: Productive Cough, Tooth Deposit, Skin Exfoliation, Chapped Lips, Lower Respiratory Tract Infection, Walking AID User, Oral Mucosal Exfoliation, Poor Quality Sleep, Balance Disorder, Postoperative Wound Complication, Oral Candidiasis, Leukoplakia Oral, Cardiac Failure Congestive, Stomatitis, Pneumonia, Oropharyngeal Plaque, Dyspnoea, Dysphagia, Mass, Dental Caries, Drug Withdrawal Syndrome, Ill-Defined Disorder, Convulsion, Gingival Pain, Oral Pain, Dysphonia, Respiratory Tract Infection, Asthenia, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Atrovent
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-01
Advair Diskus 100 / 50
Dosage: 1puff twice per day
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2010-11-01
Flovent
Dosage: 2puff twice per day
Indication: Product Used FOR Unknown Indication
End date: 2010-11-01
Other drugs received by patient: Oxycodone Hydrochloride; Pantoprazole Sodium; Arimidex; Vitamin D; Calcium Carbonate; Folic Acid; Glucosamine; Albuterol; Oxycodone Hydrochloride; Senokot; Calcium; Zinc Sulfate; Vitamin B1 TAB; Tylenol W / Codeine NO. 3; Lyrica; Diazepam; Diclofenac Sodium; Vitamin B6; Lovaza; Bisacodyl; Aspirin; Listerine; Alendronate Sodium; Vitamin B Complex CAP; Vitamin B-12; Mouth Rinse; Metoclopramide; Gravol TAB; Magnesium; Herceptin
Possible Atrovent side effects in female
Reported by a consumer/non-health professional from Canada on 2012-03-23
Patient: female, weighing 59.1 kg (130.0 pounds)
Reactions: Skin Exfoliation, Chapped Lips, Oral Mucosal Exfoliation, Walking AID User, Lower Respiratory Tract Infection, Poor Quality Sleep, Balance Disorder, Oral Candidiasis, Postoperative Wound Complication, Leukoplakia Oral, Cardiac Failure Congestive, Dyspnoea, Oropharyngeal Plaque, Dysphagia, Stomatitis, Pneumonia, Mass, Drug Withdrawal Syndrome, Ill-Defined Disorder, Gingival Pain, Oral Pain, Dysphonia, Asthenia, Respiratory Tract Infection, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Advair Diskus 100 / 50
Dosage: 1puff twice per day
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2010-11-01
Atrovent
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-01
Flovent
Dosage: 2puff twice per day
Indication: Product Used FOR Unknown Indication
End date: 2010-11-01
Other drugs received by patient: Albuterol; Diazepam; Arimidex; Diclofenac Sodium; Aspirin; Metoclopramide; Calcium Carbonate; Vitamin B6; Magnesium; Pantoprazole Sodium; Alendronate Sodium; Vitamin D; Vitamin B Complex CAP; Vitamin B-12; Listerine; Lovaza; Lyrica; Folic Acid; Vitamin B1 TAB; Senokot; Zinc Sulfate; Mouth Rinse; Oxycodone HCL; Oxycodone HCL; Gravol TAB; Bisacodyl; Calcium Carbonate; Glucosamine; Herceptin
Possible Atrovent side effects in male
Reported by a physician from France on 2012-03-05
Patient: male
Reactions: Confusional State, Bradypnoea, Polyuria, Disorientation, Aortic Thrombosis, Pulmonary Function Test Decreased, Tachypnoea, Streptococcal Sepsis, Use of Accessory Respiratory Muscles, Hypovolaemia, Decreased Appetite, Metabolic Acidosis, Vomiting, Tachyarrhythmia, Hypotension, General Physical Health Deterioration, Livedo Reticularis, Convulsion, Renal Failure, Diarrhoea, Dehydration, Disturbance in Attention, Asthenia, Extremity Necrosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Immune Globulin Intravenous (Human)
Indication: Immunodeficiency
End date: 2011-12-28
Fluticasone Propionate / Salmeterol
Dosage: 1000mcg twice per day
Indication: Asthma
End date: 2012-01-05
Theophylline
Dosage: 400mg twice per day
Administration route: Oral
Indication: Asthma
End date: 2012-01-05
Atrovent
Dosage: 1puff twice per day
Indication: Asthma
End date: 2012-01-05
Trandolapril
Dosage: 2mg per day
Administration route: Oral
End date: 2012-01-05
Other drugs received by patient: Prednisone TAB; Calcium Carbonate; Folic Acid; Xanax; Lansoprazole; Kaleorid LP; Desloratadine; Bricanyl; Mirtazapine; Gaviscon
Possible Atrovent side effects in male
Reported by a physician from France on 2012-02-28
Patient: male
Reactions: Confusional State, Bradypnoea, Polyuria, Respiratory Depression, Multi-Organ Failure, Death, Overdose, Streptococcal Sepsis, Tachypnoea, Unevaluable Event, Use of Accessory Respiratory Muscles, Decreased Appetite, Hypovolaemia, Vomiting, Metabolic Acidosis, Tachyarrhythmia, Hyperglycaemia, Hypotension, Atrial Fibrillation, Livedo Reticularis, Convulsion, Renal Failure, Diarrhoea, Dehydration, Gastroenteritis, Depressed Level of Consciousness, Skin Necrosis, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Aminophylline
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Fluticasone Propionate / Salmeterol
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Trandolapril
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Immune Globulin (Human)
Indication: Product Used FOR Unknown Indication
End date: 2011-12-28
Atrovent
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Other drugs received by patient: Mirtazapine; Xanax; Prednisone TAB; Lansoprazole; Calcidose Vitamine D; Bricanyl; Gaviscon; Desloratadine; Potassium Chloride; Folic Acid
Possible Atrovent side effects in male
Reported by a physician from France on 2012-02-24
Patient: male
Reactions: Confusional State, Bradypnoea, Polyuria, Respiratory Depression, Multi-Organ Failure, Death, Overdose, Streptococcal Sepsis, Tachypnoea, Unevaluable Event, Use of Accessory Respiratory Muscles, Decreased Appetite, Hypovolaemia, Metabolic Acidosis, Vomiting, Tachyarrhythmia, Hypotension, Hyperglycaemia, Atrial Fibrillation, Livedo Reticularis, Convulsion, Renal Failure, Diarrhoea, Dehydration, Depressed Level of Consciousness, Gastroenteritis, Skin Necrosis, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Aminophylline
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Atrovent
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Fluticasone Propionate / Salmeterol
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Immunoglobulins, Normal Human
Indication: Product Used FOR Unknown Indication
End date: 2011-12-28
Trandolapril
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-01-05
Other drugs received by patient: Xanax; Bricanyl; Potassium Chloride; Calcidose Vitamine D; Prednisone TAB; Mirtazapine; Gaviscon; Lansoprazole; Folic Acid; Desloratadine
|